We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+13.4%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$242B
AUM Growth
+$21.5B
Cap. Flow
-$6.23B
Cap. Flow %
-2.57%
Top 10 Hldgs %
14.62%
Holding
8,700
New
579
Increased
2,998
Reduced
3,843
Closed
903

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$716M
2
AMZN icon
Amazon
AMZN
+$685M
3
GOVT icon
iShares US Treasury Bond ETF
GOVT
+$508M
4
JPM icon
JPMorgan Chase
JPM
+$403M
5
COST icon
Costco
COST
+$347M

Sector Composition

Rank Sector Weight
1 Technology 9.65%
2 Financials 6.89%
3 Healthcare 6.2%
4 Consumer Discretionary 5.88%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLTM icon
6726
GraniteShares Platinum Shares
PLTM
$176M
$11K ﹤0.01%
1,285
-485
-27% -$3.98K
QFIN icon
6727
Qfin Holdings
QFIN
$1.69B
$11K ﹤0.01%
688
-80
-10% -$1.14K
RVPH
6728
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$11K ﹤0.01%
+55
New +$11K
SNDX icon
6729
Syndax Pharmaceuticals
SNDX
$1.7B
$11K ﹤0.01%
2,000
-8,469
-81% -$48.3K
SNGX icon
6730
Soligenix
SNGX
$5.6M
$11K ﹤0.01%
52
+10
+24% +$2.26K
TMQ
6731
Trilogy Metals
TMQ
$553M
$11K ﹤0.01%
4,490
+2,924
+187% +$6.41K
XYLO
6732
DELISTED
Xylo Technologies
XYLO
$11K ﹤0.01%
+91
New +$10.2K
TEN
6733
Tsakos Energy Navigation Ltd
TEN
$1.19B
$11K ﹤0.01%
730
-1,383
-65% -$22.2K
PVLA
6734
Palvella Therapeutics
PVLA
$2.02B
$11K ﹤0.01%
40
-335
-89% -$79.6K
AXNX
6735
DELISTED
Axonics, Inc. Common Stock
AXNX
$11K ﹤0.01%
473
-3,400
-88% -$61.7K
GRTS
6736
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$11K ﹤0.01%
800
-2,243
-74% -$30K
AINC
6737
DELISTED
Ashford Inc.
AINC
$11K ﹤0.01%
203
-842
-81% -$48.4K
MODN
6738
DELISTED
MODEL N, INC.
MODN
$11K ﹤0.01%
635
-10,291
-94% -$165K
ALYA
6739
DELISTED
Alithya Group Inc Class A Subordinate Voting Shares
ALYA
$11K ﹤0.01%
3,314
DMK
6740
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$11K ﹤0.01%
72
NMRD
6741
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
$11K ﹤0.01%
1,046
+788
+305% +$8.31K
CTG
6742
DELISTED
Computer Task Group, Inc.
CTG
$11K ﹤0.01%
2,510
+81
+3% +$344
FLIY
6743
DELISTED
Franklin FTSE Italy ETF
FLIY
$11K ﹤0.01%
459
+160
+54% +$3.53K
LTRPB
6744
DELISTED
Liberty TripAdvisor Holdings, Inc. Series B
LTRPB
$11K ﹤0.01%
741
+4
+0.5% +$66
HVBC
6745
DELISTED
HV Bancorp, Inc. Common Stock
HVBC
$11K ﹤0.01%
+687
New +$10.7K
MAXR
6746
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$11K ﹤0.01%
2,617
+1,600
+157% +$9.41K
DTEA
6747
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
$11K ﹤0.01%
+7,663
New +$10.8K
NVCN
6748
DELISTED
Neovasc Inc.
NVCN
$11K ﹤0.01%
104
+91
+700% +$13.6K
WVFC
6749
DELISTED
WVS Financial Corp
WVFC
$11K ﹤0.01%
620
-408
-40% -$6.69K
BFRA
6750
DELISTED
Biofrontera AG American Depositary Shares
BFRA
$11K ﹤0.01%
871
-625
-42% -$7.88K

Similar funds

UBS Group's Q1 2019 Portfolio in Review

As of Q1 2019, UBS Group held 8,700 positions worth $242B, up 9.8% from $221B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

UBS Group's Q1 2019 filing shows 579 new, 2,998 increased, 3,843 reduced and 903 closed positions. Its largest new stake was PIMCO Dynamic Income Strategy Fund: 753,726 shares worth $15.4M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.53B.

By sector, the portfolio is most concentrated in Technology at 9.6% of assets, up from 8% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q1 2019 buy was PIMCO Dynamic Income Strategy Fund: 753,726 shares worth $15.4M.
  • UBS Group added most to Microsoft in Q1 2019, an estimated $716M increase.
  • UBS Group's biggest Q1 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.53B.
  • UBS Group fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $341M.
  • UBS Group's ten largest holdings make up 15% of its $242B portfolio in Q1 2019.
  • UBS Group opened 579 new positions and closed 903 in Q1 2019.
  • UBS Group's portfolio value rose 9.8% quarter-over-quarter to $242B.

Based on UBS Group's 13F filing for Q1 2019, filed 14 May 2019.